World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
61
Citations
12892
World Ranking
3243
National Ranking
127

Overview

Wilma Barcellini is affiliated with the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico in Italy. Their research output focuses predominantly on the field of Medicine, with a strong emphasis on Hematology. Additional subfields of study include Genetics, Physiology, Immunology, and Infectious Diseases.

The scientist's work spans several main topics, notably:

  • Blood groups and transfusion
  • Erythrocyte Function and Pathophysiology
  • Blood disorders and treatments
  • Hemoglobinopathies and Related Disorders
  • Complement system in diseases
  • Platelet Disorders and Treatments
  • Immunodeficiency and Autoimmune Disorders

Barcellini's recent notable publications include:

  • "Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia," 2022, New England Journal of Medicine
  • "Sutimlimab in Cold Agglutinin Disease," 2021, New England Journal of Medicine
  • "Recommendations for diagnosis and treatment of methemoglobinemia," 2021, American Journal of Hematology
  • "Autoimmune Hemolytic Anemias," 2021, New England Journal of Medicine
  • "Cold agglutinin disease revisited: a multinational, observational study of 232 patients," 2020, Blood

Frequent co-authorships have been established with:

  • Bruno Fattizzo
  • Juri Alessandro Giannotta
  • Paola Bianchi
  • Anna Zaninoni
  • Marta Bortolotti

Major publication venues for Barcellini's research include:

  • Blood
  • HemaSphere
  • American Journal of Hematology
  • Frontiers in Immunology
  • Blood Advances

Best Publications

  • Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting

    Ulrich Jäger;Wilma Barcellini;Catherine M. Broome;Morie A. Gertz

  • Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients.

    Wilma Barcellini;Bruno Fattizzo;Anna Zaninoni;Tommaso Radice

  • Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia

    W. Barcellini;B. Fattizzo

  • Treatment of autoimmune hemolytic anemias

    Alberto Zanella;Wilma Barcellini

  • TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients

    Wilma Barcellini;Gian Paolo Rizzardi;Maria Orietta Borghi;Cristina Fain

  • Recommendations regarding splenectomy in hereditary hemolytic anemias

    Achille Iolascon;Immacolata Andolfo;Wilma Barcellini;Francesco Corcione

  • Clinical and hematologic features of 300 patients affected by hereditary spherocytosis grouped according to the type of the membrane protein defect

    Mariagabriella Mariani;Wilma Barcellini;Cristina Vercellati;Anna Paola Marcello

  • Sutimlimab in Cold Agglutinin Disease.

    Alexander Röth;Wilma Barcellini;Shirley D’Sa;Yoshitaka Miyakawa

  • Autoimmune Hemolytic Anemias.

    Sigbjørn Berentsen;Wilma Barcellini

  • New Insights in the Pathogenesis of Autoimmune Hemolytic Anemia.

    Wilma Barcellini

  • Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study.

    Rachael F. Grace;Paola Bianchi;Eduard J. van Beers;Stefan W. Eber

  • Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus.

    A. Vismara;P. L. Meroni;Angela Tincani;E. N. Harris

  • Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies.

    Wilma Barcellini;Francesco Zaja;Anna Zaninoni;Francesca Guia Imperiali

  • Anti-endothelial cell antibodies in patients with Wegener's granulomatosis and micropolyarteritis.

    G. Ferraro;P. L. Meroni;A. Tincani;A. Sinico

  • Protection from experimental autoimmune diabetes in the non‐obese diabetic mouse with soluble interleukin‐1 receptor

    F Nicoletti;R Di Marco;W Barcellini;G Magro

  • Autoimmune cytopenias in chronic lymphocytic leukemia.

    Carlo Visco;Wilma Barcellini;Francesco Maura;Francesco Maura;Antonino Neri;Antonino Neri

  • Safety and efficacy of mitapivat in pyruvate kinase deficiency

    Rachael F. Grace;Christian Rose;D. Mark Layton;Frédéric Galactéros

  • Recommendations for diagnosis and treatment of methemoglobinemia

    Achille Iolascon;Paola Bianchi;Immacolata Andolfo;Roberta Russo

  • The Changing Landscape of Autoimmune Hemolytic Anemia

    Wilma Barcellini;Bruno Fattizzo;Bruno Fattizzo

  • Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia

    Wilma Barcellini;Silvana Capalbo;Rosa Maria Agostinelli;Francesca Romana Mauro

  • How I treat warm autoimmune hemolytic anemia.

    Wilma Barcellini;Bruno Fattizzo

  • New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to Therapy Stage 1.

    Wilma Barcellini;Anna Zaninoni;Juri Alessandro Giannotta;Bruno Fattizzo

  • Plasma levels of soluble CD30, tumour necrosis factor (TNF)-α and TNF receptors during primary HIV-1 infection : correlation with HIV-1 RNA and the clinical outcome

    Rizzardi Gp;Barcellini W;Tambussi G;Lillo F

Frequent Co-Authors

Pier Luigi Meroni
Pier Luigi Meroni Istituto Auxologico Italiano
Maria Orietta Borghi
Maria Orietta Borghi University of Milan
Dario Consonni
Dario Consonni University of Milan
Antonino Neri
Antonino Neri University of Milan
Adriano Lazzarin
Adriano Lazzarin Vita-Salute San Raffaele University
Francesco Rodeghiero
Francesco Rodeghiero Yamagata University
Maria Domenica Cappellini
Maria Domenica Cappellini University of Milan
Wendy B. London
Wendy B. London Harvard University
Peter E. Newburger
Peter E. Newburger University of Massachusetts Chan Medical School
Luca Agnelli
Luca Agnelli University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond Immunology, pursuing nursing-related degrees online offers a flexible pathway to advance your healthcare career. Programs such as 12-month accelerated nursing programs online for non nurses provide an efficient route for individuals transitioning into nursing without prior experience. These programs are designed to build foundational skills quickly, preparing students for various healthcare roles.

If you are seeking programs with less competitive entry requirements, exploring the easiest ABSN program to get into can help streamline your acceptance into a nursing curriculum. Similarly, knowing which LPN programs are easiest to get into is valuable for those aiming to start with practical nursing credentials before specializing further.

Advancing to practitioner-level roles is also achievable through the easiest nurse practitioner degree programs available online. These pathways offer opportunities to enhance your clinical skills and open doors to leadership positions in healthcare settings.

By combining an Immunology background with these online nursing degrees, healthcare professionals can diversify their expertise and career options in the growing medical field.

Best Scientists Citing Wilma Barcellini

Trending Scientists

Recently Published Articles